Literature DB >> 8285709

Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions.

M F Bernet1, D Brassart, J R Neeser, A L Servin.   

Abstract

Thirteen human bifidobacterial strains were tested for their abilities to adhere to human enterocyte-like Caco-2 cells in culture. The adhering strains were also tested for binding to the mucus produced by the human mucus-secreting HT29-MTX cell line in culture. A high level of calcium-independent adherence was observed for Bifidobacterium breve 4, for Bifidobacterium infantis 1, and for three fresh human isolates from adults. As observed by scanning electron microscopy, adhesion occurs to the apical brush border of the enterocytic Caco-2 cells and to the mucus secreted by the HT29-MTX mucus-secreting cells. The bacteria interacted with the well-defined apical microvilli of Caco-2 cells without cell damage. The adhesion to Caco-2 cells of bifidobacteria did not require calcium and was mediated by a proteinaceous adhesion-promoting factor which was present both in the bacterial whole cells and in the spent supernatant of bifidobacterium culture. This adhesion-promoting factor appeared species specific, as are the adhesion-promoting factors of lactobacilli. We investigated the inhibitory effect of adhering human bifidobacterial strains against intestinal cell monolayer colonization by a variety of diarrheagenic bacteria. B. breve 4, B. infantis 1, and fresh human isolates were shown to inhibit cell association of enterotoxigenic, enteropathogenic, diffusely adhering Escherichia coli and Salmonella typhimurium strains to enterocytic Caco-2 cells in a concentration-dependent manner. Moreover, B. breve 4 and B. infantis 1 strains inhibited, dose dependently, Caco-2 cell invasion by enteropathogenic E. coli, Yersinia pseudotuberculosis, and S. typhimurium strains.

Entities:  

Mesh:

Year:  1993        PMID: 8285709      PMCID: PMC195875          DOI: 10.1128/aem.59.12.4121-4128.1993

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  38 in total

1.  Survival of Lactobacillus species (strain GG) in human gastrointestinal tract.

Authors:  B R Goldin; S L Gorbach; M Saxelin; S Barakat; L Gualtieri; S Salminen
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

2.  Characterization of interactions of enteropathogenic Escherichia coli O127:H6 with mammalian cells in vitro.

Authors:  C L Francis; A E Jerse; J B Kaper; S Falkow
Journal:  J Infect Dis       Date:  1991-10       Impact factor: 5.226

3.  Purification and characterization of the CFA/I antigen of enterotoxigenic Escherichia coli.

Authors:  D G Evans; D J Evans; S Clegg; J A Pauley
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

4.  Adherence of cervical, vaginal and distal urethral normal microbial flora to human uroepithelial cells and the inhibition of adherence of gram-negative uropathogens by competitive exclusion.

Authors:  R C Chan; A W Bruce; G Reid
Journal:  J Urol       Date:  1984-03       Impact factor: 7.450

Review 5.  One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.

Authors:  J Fogh; J M Fogh; T Orfeo
Journal:  J Natl Cancer Inst       Date:  1977-07       Impact factor: 13.506

6.  The human intestinal microflora.

Authors:  G L Simon; S L Gorbach
Journal:  Dig Dis Sci       Date:  1986-09       Impact factor: 3.199

7.  Adherence of Lactobacillus species to human fetal intestinal cells.

Authors:  E G Kleeman; T R Klaenhammer
Journal:  J Dairy Sci       Date:  1982-11       Impact factor: 4.034

8.  Inhibition of adhesion of Escherichia coli K88 to piglet ileal mucus by Lactobacillus spp.

Authors:  L Blomberg; A Henriksson; P L Conway
Journal:  Appl Environ Microbiol       Date:  1993-01       Impact factor: 4.792

9.  Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments.

Authors:  R C Chan; G Reid; R T Irvin; A W Bruce; J W Costerton
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

Review 10.  Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent.

Authors:  M M Levine
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

View more
  72 in total

Review 1.  Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?

Authors:  G T Macfarlane; J H Cummings
Journal:  BMJ       Date:  1999-04-10

2.  Genomic diversity and relatedness of bifidobacteria isolated from a porcine cecum.

Authors:  P J Simpson; C Stanton; G F Fitzgerald; R P Ross
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

3.  In vitro growth responses of bifidobacteria and enteropathogens to bovine and human lactoferrin.

Authors:  Elizabeth A Griffiths; Linda C Duffy; Floyd L Schanbacher; Diane Dryja; Allen Leavens; Ronald L Neiswander; Haiping Qiao; Douglas DiRienzo; Pearay Ogra
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

4.  In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice.

Authors:  Elizabeth A Griffiths; Linda C Duffy; Floyd L Schanbacher; Haiping Qiao; Diane Dryja; Allen Leavens; Jon Rossman; Gary Rich; Douglas Dirienzo; Pearay L Ogra
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

Review 5.  The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 6.  Proposed model: mechanisms of immunomodulation induced by probiotic bacteria.

Authors:  C Maldonado Galdeano; A de Moreno de LeBlanc; G Vinderola; M E Bibas Bonet; G Perdigón
Journal:  Clin Vaccine Immunol       Date:  2007-03-14

7.  Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?

Authors:  G T Macfarlane; J H Cummings
Journal:  West J Med       Date:  1999-09

8.  Selection of bifidobacteria based on adhesion and anti-inflammatory capacity in vitro for amelioration of murine colitis.

Authors:  Julia Preising; David Philippe; Marita Gleinser; Hua Wei; Stephanie Blum; Bernhard J Eikmanns; Jan-Hendrik Niess; Christian U Riedel
Journal:  Appl Environ Microbiol       Date:  2010-03-12       Impact factor: 4.792

9.  Bifidobacteria isolated from infants and cultured on human milk oligosaccharides affect intestinal epithelial function.

Authors:  Maciej Chichlowski; Guillaume De Lartigue; J Bruce German; Helen E Raybould; David A Mills
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-09       Impact factor: 2.839

10.  Expression of fluorescent proteins in bifidobacteria for analysis of host-microbe interactions.

Authors:  Verena Grimm; Marita Gleinser; Caroline Neu; Daria Zhurina; Christian U Riedel
Journal:  Appl Environ Microbiol       Date:  2014-02-28       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.